help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arbustini, E.
Right arrow Articles by Viganò, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arbustini, E.
Right arrow Articles by Viganò, M.
(American Journal of Pathology. 1998;153:1501-1510.)
© 1998 American Society for Investigative Pathology


Regular Articles

Mitochondrial DNA Mutations and Mitochondrial Abnormalities in Dilated Cardiomyopathy

Eloisa Arbustini* , Marta Diegoli* , Roberta Fasani* , Maurizia Grasso{dagger} , Patrizia Morbini* , Nadia Banchieri* , Ornella Bellini* , Barbara Dal Bello* , Andrea Pilotto* , Giulia Magrini{ddagger} , Carlo Campana{ddagger} , Paolo Fortina§ , Antonello Gavazzi{ddagger} , Jagat Narula¶ and Mario Viganò||

From the Cardiovascular Pathology and Molecular Diagnostic* and Research Transplantation Laboratories{dagger} and the Departments of Cardiology{ddagger} and Cardiac Surgery,|| Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy; Children's Hospital of Philadelphia,§ University of Pennsylvania, and Allegheny University Hospitals of Health Sciences, Philadelphia, Pennsylvania

Mitochondrial (mt)DNA defects, both deletions and tRNA point mutations, have been associated with cardiomyopathies. The aim of the study was to determine the prevalence of pathological mtDNA mutations and to assess associated defects of mitochondrial enzyme activity in dilated cardiomyopathy (DCM) patients with ultrastructural abnormalities of cardiac mitochondria. In a large cohort of 601 DCM patients we performed conventional light and electron microscopy on endomyocardial biopsy samples. Cases with giant organelles, angulated, tubular, and concentric cristae, and crystalloid or osmiophilic inclusion bodies were selected for mtDNA analysis. Mutation screening techniques, automated DNA sequencing, restriction enzyme digestion, and densitometric assays were performed to identify mtDNA mutations, assess heteroplasmy, and quantify the amount of mutant in myocardial and blood DNA. Of 601 patients (16 to 63 years; mean, 43.5 ± 12.7 years), 85 had ultrastructural evidence of giant organelles, with abnormal cristae and inclusion bodies; 19 of 85 (22.35%) had heteroplasmic mtDNA mutations (9 tRNA, 5 rRNA, and 4 missense, one in two patients) that were not found in 111 normal controls and in 32 DCM patients without the above ultrastructural mitochondrial abnormalities. In all cases, the amount of mutant was higher in heart than in blood. In hearts of patients that later underwent transplantation, cytochrome c oxidase (Cox) activity was significantly lower in cases with mutations than in those without or controls (P = 0.0008). NADH dehydrogenase activity was only slightly reduced in cases with mutations (P = 0.0388), whereas succinic dehydrogenase activity did not significantly differ between DCM patients with mtDNA mutations and those without or controls. The present study represents the first attempt to detect a morphological, easily identifiable marker to guide mtDNA mutation screening. Pathological mtDNA mutations are associated with ultrastructurally abnormal mitochondria, and reduced Cox activity in a small subgroup of non-otherwise-defined, idiopathic DCMs, in which mtDNA defects may constitute the basis for, or contribute to, the development of congestive heart failure.





This article has been cited by other articles:


Home page
Eur Heart JHome page
K. Unno, S. Isobe, H. Izawa, X. W. Cheng, M. Kobayashi, A. Hirashiki, T. Yamada, K. Harada, S. Ohshima, A. Noda, et al.
Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy
Eur. Heart J., May 24, 2009; (2009) ehp184v1.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
R. E. Hershberger, J. Cowan, A. Morales, and J. D. Siegfried
Progress With Genetic Cardiomyopathies: Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Circ Heart Fail, May 1, 2009; 2(3): 253 - 261.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Tsutsui, S. Kinugawa, and S. Matsushima
Mitochondrial oxidative stress and dysfunction in myocardial remodelling
Cardiovasc Res, February 15, 2009; 81(3): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. C. Sparagna, A. J. Chicco, R. C. Murphy, M. R. Bristow, C. A. Johnson, M. L. Rees, M. L. Maxey, S. A. McCune, and R. L. Moore
Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure
J. Lipid Res., July 1, 2007; 48(7): 1559 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Bergman, J. R. Teerlink, R. Mahimkar, L. Li, B.-Q. Zhu, A. Nguyen, S. Dahi, J. S. Karliner, and D. H. Lovett
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1847 - H1860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Nojiri, T. Shimizu, M. Funakoshi, O. Yamaguchi, H. Zhou, S. Kawakami, Y. Ohta, M. Sami, T. Tachibana, H. Ishikawa, et al.
Oxidative Stress Causes Heart Failure with Impaired Mitochondrial Respiration
J. Biol. Chem., November 3, 2006; 281(44): 33789 - 33801.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ikeuchi, H. Matsusaka, D. Kang, S. Matsushima, T. Ide, T. Kubota, T. Fujiwara, N. Hamasaki, A. Takeshita, K. Sunagawa, et al.
Overexpression of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies and Cardiac Failure After Myocardial Infarction
Circulation, August 2, 2005; 112(5): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. L. Burkett and R. E. Hershberger
Clinical and genetic issues in familial dilated cardiomyopathy
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 969 - 981.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Omura, M. Yoshiyama, T. Hayashi, S. Nishiguchi, M. Kaito, S. Horiike, K. Fukuda, S. Inamoto, Y. Kitaura, Y. Nakamura, et al.
Core Protein of Hepatitis C Virus Induces Cardiomyopathy
Circ. Res., February 4, 2005; 96(2): 148 - 150.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
C. Bruno, O. Sacco, F. M. Santorelli, S. Assereto, E. Tonoli, M. Bado, G. A. Rossi, and C. Minetti
Mitochondrial Myopathy and Respiratory Failure Associated With a New Mutation in the Mitochondrial Transfer Ribonucleic Acid Glutamic Acid Gene
J Child Neurol, April 1, 2003; 18(4): 300 - 303.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. T. Lucas, P. Aryal, L. I. Szweda, W. J. Koch, and L. A. Leinwand
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H575 - H583.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Scheubel, M. Tostlebe, A. Simm, S. Rohrbach, R. Prondzinsky, F. N. Gellerich, R.-E. Silber, and J. Holtz
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2174 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Fatkin and R. M. Graham
Molecular Mechanisms of Inherited Cardiomyopathies
Physiol Rev, October 1, 2002; 82(4): 945 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. Tham, J. Wang, F. Piehl, and G. Weber
Upregulation of VEGF-A Without Angiogenesis in a Mouse Model of Dilated Cardiomyopathy Caused by Mitochondrial Dysfunction
J. Histochem. Cytochem., July 1, 2002; 50(7): 935 - 944.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Ide, H. Tsutsui, S. Hayashidani, D. Kang, N. Suematsu, K.-i. Nakamura, H. Utsumi, N. Hamasaki, and A. Takeshita
Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction
Circ. Res., March 16, 2001; 88(5): 529 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A Santel and M. Fuller
Control of mitochondrial morphology by a human mitofusin
J. Cell Sci., January 3, 2001; 114(5): 867 - 874.
[Abstract] [PDF]


Home page
Eur Heart JHome page
A. Gavazzi, A. Repetto, L. Scelsi, C. Inserra, M.L. Laudisa, C. Campana, C. Specchia, B. Dal Bello, M. Diegoli, L. Tavazzi, et al.
Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy. Prevalence, inheritance and characteristics
Eur. Heart J., January 1, 2001; 22(1): 73 - 81.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
J. Marin-Garcia, M. J Goldenthal, and G. W Moe
Mitochondrial pathology in cardiac failure
Cardiovasc Res, January 1, 2001; 49(1): 17 - 26.
[Full Text] [PDF]


Home page
J Child NeurolHome page
A. Shtilbans, M. El-Schahawi, E. Malkin, S. Shanske, O. Musumeci, and S. DiMauro
A Novel Mutation in the Mitochondrial DNA Transfer Ribonucleic AcidAsp Gene in a Child With Myoclonic Epilepsy and Psychomotor Regression
J Child Neurol, September 1, 1999; 14(9): 610 - 613.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.